Topic: Accreditation & Evaluation Platforms
What De-identification Misses: Trust and Secondary Use in Digital Mental Health
This article explores the governance gap that emerges when de-identified mental health records are linked, analysed, and reused, and asks how obligations of trust and confidentiality should follow what has been learned about a person.
Promise and Pressure: Building Digital Mental Health People Can Trust
Digital mental health is creating new pathways to care, connection and earlier intervention, but its promise depends on whether people can trust the technologies they use. Maureen Abbott explores how safety, evidence, equity and human-centred design can help ensure digital
The Hague Roundtable: Lived Experience Informing the Way Forward
MHRA Issues New Guidance for People Using Mental Health Apps and Technologies
The MHRA, in partnership with NHS England, has launched free online guidance to help the public, carers, and professionals identify safe, effective, and evidence-based digital mental health technologies, including clear advice on claims, suitability, data use, regulation, and how to
Bridging the Digital Divide: A Toolkit for Equity-Centred Regulation of Digital Mental Health
A newly released toolkit outlines how equity can be embedded into the regulation and development of digital mental health technologies, helping ensure digital tools reduce risk and address, rather than deepen, mental health inequalities.
Innovations to Improve Outcomes and Uptake of Psychotherapies for Mental Disorders: a State-Of-The-Art Review (Key Takeaways)
Innovations in psychotherapy and digital mental health continue to advance through incremental gains, with growing evidence for the effectiveness and scalability of digital, simplified, and workforce-adaptive models rather than any single transformative breakthrough.
MHRA and NICE Receive £2 Million from Wellcome to Improve Safety and Effectiveness of Digital Mental Health Technologies
UK regulators MHRA and NICE have received £2 million from Wellcome to strengthen frameworks for the safe, effective, and evidence-based use of digital mental health technologies.
FDA Clears Deep TMS™ for Adolescents With Major Depressive Disorder
The FDA has cleared BrainsWay’s Deep TMS™ system as an adjunct treatment for adolescents aged 15–21 with major depressive disorder, expanding access to a noninvasive, evidence-based therapy previously available only to adults.
The States Step In to Regulate AI: A Policy Vacuum Filled by Local Action in the United States
US states are leading the regulation of AI in mental health by demanding transparency and oversight, but a major policy gap remains in mandating comprehensive AI safety protocols.
FDA to Review AI Mental Health Devices: Setting the Stage for Regulation
The US FDA’s Digital Health Advisory Committee (DHAC) will meet on November 6, 2025 to evaluate AI-enabled digital mental health devices (including chatbots and virtual therapists) to explore how they could bridge the mental health service access gap while assessing
Upcoming Events
Webinar Replays
Member Login
Our Audience
eMHIC has and audience of 26 member countries (and growing) with thousands of subscribers around the world.
Share your thoughts
Have quality news or resources to share on the eMHIC Knowledge Bank? We’d love to consider publishing them for our global community.
